Literature DB >> 28956765

Control of the HIV-1 DNA Reservoir Is Associated In Vivo and In Vitro with NKp46/NKp30 (CD335 CD337) Inducibility and Interferon Gamma Production by Transcriptionally Unique NK Cells.

Francesco Marras1, Anna Casabianca2, Federica Bozzano1,3, Maria Libera Ascierto4, Chiara Orlandi2, Antonio Di Biagio5, Emanuele Pontali6, Chiara Dentone7, Giancarlo Orofino8, Laura Nicolini5,9, Lucia Taramasso9, Mauro Magnani2, Francesco M Marincola10, Ena Wang10, Lorenzo Moretta11, Andrea De Maria12,5,9.   

Abstract

The size of lentiviral DNA reservoirs reflects the effectiveness of immune responses against lentiviruses. So far, abundant information has been gathered on the control of HIV-1 replication. Understanding the innate mechanisms contributing to containment of the HIV DNA reservoir, however, are only partly clarified and are relevant to guiding interventions for reservoir containment or eradication. We studied the contribution of natural killer (NK) cell functional features in HIV patients controlling replication either spontaneously (HIV controllers [HIC]) or after progression and antiretroviral treatment (progressor patients [PP]). An inverse correlation between HIV DNA copy numbers (either total or integrated) in circulating CD4+ cells and NK cell function was observed. Induced interferon gamma (IFN-γ) production and NKp46/NKp30 activating receptor-induced expression correlated inversely with reservoir size. The correlation was present not only for a homogeneous cohort of HIC patients but also when PP were included in the analysis. Adaptive (NKG2C+ CD57+) NK cell features were not associated with reservoir size. However, a distinct set of 370 differentially expressed transcripts was found to underlie functional differences in NK cells controlling HIV DNA reservoir size. In proof-of-principle in vitro experiments of CD4+ cell infection with HIV-1, purified NK cells with the above-mentioned functional/transcriptional features displayed 10- and 30-fold higher abilities to control HIV replication and DNA burdens in vitro, respectively, than those of other NK cells. Thus, NK cells with a specific functional and transcriptional signature contribute to control of the HIV reservoir in CD4+ cells. Their selection, expansion, and/or adoptive transfer may support strategies to eradicate HIV-1 infection or to safely deescalate antiretroviral treatment.IMPORTANCE The most relevant feature of HIV-1 infection is represented by its DNA reservoir size in the body, which guarantees lifelong infection and resumption of virus replication after antiretroviral treatment interruption. So far, there has been little success in the identification of factors contributing to HIV-1 reservoir containment. In this study, by studying quantitative total and integrated HIV-1 DNA levels and NK cells in HIV-1 patients with either progressive or nonprogressive disease, we observed that inducible IFN-γ and natural cytotoxicity receptor (NCR) expression in a specific subset of NK cells with a characteristic transcriptional signature represents a correlate for HIV-1 reservoir control. This represents an advance in our understanding of the mechanism(s) that controls the lentivirus reservoir. Monitoring, selection, expansion, and adoptive transfer of these NK cells may allow monitoring of treatment efficacy and the likelihood of reservoir control and may support protocols for HIV-1 eradication.
Copyright © 2017 American Society for Microbiology.

Entities:  

Keywords:  DNA; HIV-1; interferons; lentiviruses; natural killer cells; reservoir

Mesh:

Substances:

Year:  2017        PMID: 28956765      PMCID: PMC5686752          DOI: 10.1128/JVI.00647-17

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  78 in total

1.  Fatal varicella associated with selective natural killer cell deficiency.

Authors:  Amos Etzioni; Celine Eidenschenk; Rina Katz; Rafeal Beck; Jean Laurent Casanova; Shimon Pollack
Journal:  J Pediatr       Date:  2005-03       Impact factor: 4.406

2.  Increased natural cytotoxicity receptor expression and relevant IL-10 production in NK cells from chronically infected viremic HCV patients.

Authors:  Andrea De Maria; Manuela Fogli; Stefania Mazza; Monica Basso; Antonio Picciotto; Paola Costa; Sonia Congia; Maria Cristina Mingari; Lorenzo Moretta
Journal:  Eur J Immunol       Date:  2007-02       Impact factor: 5.532

3.  Analysis of memory-like natural killer cells in human cytomegalovirus-infected children undergoing αβ+T and B cell-depleted hematopoietic stem cell transplantation for hematological malignancies.

Authors:  Letizia Muccio; Alice Bertaina; Michela Falco; Daniela Pende; Raffaella Meazza; Miguel Lopez-Botet; Lorenzo Moretta; Franco Locatelli; Alessandro Moretta; Mariella Della Chiesa
Journal:  Haematologica       Date:  2015-12-11       Impact factor: 9.941

4.  Virologically suppressed HIV patients show activation of NK cells and persistent innate immune activation.

Authors:  Gregor F Lichtfuss; Wan-Jung Cheng; Yagmur Farsakoglu; Geza Paukovics; Reena Rajasuriar; Pushparaj Velayudham; Marit Kramski; Anna C Hearps; Paul U Cameron; Sharon R Lewin; Suzanne M Crowe; Anthony Jaworowski
Journal:  J Immunol       Date:  2012-06-27       Impact factor: 5.422

5.  Presence of an inducible HIV-1 latent reservoir during highly active antiretroviral therapy.

Authors:  T W Chun; L Stuyver; S B Mizell; L A Ehler; J A Mican; M Baseler; A L Lloyd; M A Nowak; A S Fauci
Journal:  Proc Natl Acad Sci U S A       Date:  1997-11-25       Impact factor: 11.205

6.  Activation of natural killer cells during acute infection with hepatitis C virus.

Authors:  Barbara Amadei; Simona Urbani; Angelica Cazaly; Paola Fisicaro; Alessandro Zerbini; Parvin Ahmed; Gabriele Missale; Carlo Ferrari; Salim I Khakoo
Journal:  Gastroenterology       Date:  2010-01-18       Impact factor: 22.682

7.  Imprint of human cytomegalovirus infection on the NK cell receptor repertoire.

Authors:  Mónica Gumá; Ana Angulo; Carlos Vilches; Natalia Gómez-Lozano; Núria Malats; Miguel López-Botet
Journal:  Blood       Date:  2004-08-10       Impact factor: 22.113

8.  Peripheral T Follicular Helper Cells Are the Major HIV Reservoir within Central Memory CD4 T Cells in Peripheral Blood from Chronically HIV-Infected Individuals on Combination Antiretroviral Therapy.

Authors:  Suresh Pallikkuth; Mark Sharkey; Dunja Z Babic; Sachin Gupta; Geoffrey W Stone; Margaret A Fischl; Mario Stevenson; Savita Pahwa
Journal:  J Virol       Date:  2015-12-16       Impact factor: 5.103

9.  Functionally relevant decreases in activatory receptor expression on NK cells are associated with pulmonary tuberculosis in vivo and persist after successful treatment.

Authors:  Federica Bozzano; Paola Costa; Giovanni Passalacqua; Ferdinando Dodi; Silvia Ravera; Gabriella Pagano; Giorgio W Canonica; Lorenzo Moretta; Andrea De Maria
Journal:  Int Immunol       Date:  2009-05-21       Impact factor: 4.823

10.  Elimination of Latently HIV-infected Cells from Antiretroviral Therapy-suppressed Subjects by Engineered Immune-mobilizing T-cell Receptors.

Authors:  Hongbing Yang; Sandrine Buisson; Giovanna Bossi; Zoë Wallace; Gemma Hancock; Chun So; Rebecca Ashfield; Annelise Vuidepot; Tara Mahon; Peter Molloy; Joanne Oates; Samantha J Paston; Milos Aleksic; Namir J Hassan; Bent K Jakobsen; Lucy Dorrell
Journal:  Mol Ther       Date:  2016-06-06       Impact factor: 11.454

View more
  24 in total

1.  Early and Highly Suppressive Antiretroviral Therapy Are Main Factors Associated With Low Viral Reservoir in European Perinatally HIV-Infected Children.

Authors:  Alfredo Tagarro; Man Chan; Paola Zangari; Bridget Ferns; Caroline Foster; Anita De Rossi; Eleni Nastouli; María A Muñoz-Fernández; Diana Gibb; Paolo Rossi; Carlo Giaquinto; Abdel Babiker; Claudia Fortuny; Riccardo Freguja; Nicola Cotugno; Ali Judd; Antoni Noguera-Julian; María Luisa Navarro; María José Mellado; Nigel Klein; Paolo Palma; Pablo Rojo
Journal:  J Acquir Immune Defic Syndr       Date:  2018-10-01       Impact factor: 3.731

2.  In-vivo administration of histone deacetylase inhibitors does not impair natural killer cell function in HIV+ individuals.

Authors:  Carolina Garrido; Martin Tolstrup; Ole S Søgaard; Thomas A Rasmussen; Brigitte Allard; Natalia Soriano-Sarabia; Nancie M Archin; David M Margolis
Journal:  AIDS       Date:  2019-03-15       Impact factor: 4.177

3.  Pegylated Interferon-α-Induced Natural Killer Cell Activation Is Associated With Human Immunodeficiency Virus-1 DNA Decline in Antiretroviral Therapy-Treated HIV-1/Hepatitis C Virus-Coinfected Patients.

Authors:  Stéphane Hua; Selena Vigano; Samantha Tse; Ouyang Zhengyu; Sean Harrington; Jordi Negron; Pilar Garcia-Broncano; Giulia Marchetti; Miguel Genebat; Manuel Leal; Salvador Resino; Ezequiel Ruiz-Mateos; Mathias Lichterfeld; Xu G Yu
Journal:  Clin Infect Dis       Date:  2018-06-01       Impact factor: 9.079

4.  Interleukin-15-Stimulated Natural Killer Cells Clear HIV-1-Infected Cells following Latency Reversal Ex Vivo.

Authors:  Carolina Garrido; Maria Abad-Fernandez; Marina Tuyishime; Justin J Pollara; Guido Ferrari; Natalia Soriano-Sarabia; David M Margolis
Journal:  J Virol       Date:  2018-05-29       Impact factor: 5.103

5.  NK Response Correlates with HIV Decrease in Pegylated IFN-α2a-Treated Antiretroviral Therapy-Suppressed Subjects.

Authors:  Emmanouil Papasavvas; Livio Azzoni; Andrew V Kossenkov; Noor Dawany; Knashawn H Morales; Matthew Fair; Brian N Ross; Kenneth Lynn; Agnieszka Mackiewicz; Karam Mounzer; Pablo Tebas; Jeffrey M Jacobson; Jay R Kostman; Louise Showe; Luis J Montaner
Journal:  J Immunol       Date:  2019-06-28       Impact factor: 5.422

Review 6.  The role of IFN-γ production during retroviral infections: an important cytokine involved in chronic inflammation and pathogenesis.

Authors:  Patrícia Azevedo Soares Cordeiro; Tatiane Assone; Gabriela Prates; Marcia Regina Martinez Tedeschi; Luiz Augusto Marcondes Fonseca; Jorge Casseb
Journal:  Rev Inst Med Trop Sao Paulo       Date:  2022-09-30       Impact factor: 2.169

7.  Identification of NK Cell Subpopulations That Differentiate HIV-Infected Subject Cohorts with Diverse Levels of Virus Control.

Authors:  Christopher W Pohlmeyer; Veronica D Gonzalez; Alivelu Irrinki; Ricardo N Ramirez; Li Li; Andrew Mulato; Jeffrey P Murry; Aaron Arvey; Rebecca Hoh; Steven G Deeks; George Kukolj; Tomas Cihlar; Stefan Pflanz; Garry P Nolan; Gundula Min-Oo
Journal:  J Virol       Date:  2019-03-21       Impact factor: 5.103

8.  HIV-Specific, Ex Vivo Expanded T Cell Therapy: Feasibility, Safety, and Efficacy in ART-Suppressed HIV-Infected Individuals.

Authors:  Julia A Sung; Shabnum Patel; Matthew L Clohosey; Lauren Roesch; Tamara Tripic; JoAnn D Kuruc; Nancie Archin; Patrick J Hanley; C Russell Cruz; Nilu Goonetilleke; Joseph J Eron; Clio M Rooney; Cynthia L Gay; Catherine M Bollard; David M Margolis
Journal:  Mol Ther       Date:  2018-09-21       Impact factor: 11.454

9.  A comparative analysis of unintegrated HIV-1 DNA measurement as a potential biomarker of the cellular reservoir in the blood of patients controlling and non-controlling viral replication.

Authors:  Chiara Orlandi; Benedetta Canovari; Federica Bozzano; Francesco Marras; Zeno Pasquini; Francesco Barchiesi; Andrea De Maria; Mauro Magnani; Anna Casabianca
Journal:  J Transl Med       Date:  2020-05-19       Impact factor: 5.531

10.  Early ART initiation during infancy preserves natural killer cells in young European adolescents living with HIV (CARMA cohort).

Authors:  Margherita Doria; Sonia Zicari; Nicola Cotugno; Sara Domínguez-Rodríguez; Alessandra Ruggiero; Giuseppe R Pascucci; Alfredo Tagarro; Pablo Rojo Conejo; Eleni Nastouli; Kathleen Gärtner; Mark Cameron; Brian Richardson; Caroline Foster; Sion L Williams; Stefano Rinaldi; Anita De Rossi; Carlo Giaquinto; Paolo Rossi; Savita Pahwa; Paolo Palma
Journal:  J Int AIDS Soc       Date:  2021-07       Impact factor: 5.396

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.